Capecitabine-d11 2',3'-diacetate

SL-10237

Capecitabine-d11 2',3'-diacetate, >98%

IUPAC Name : (2R,3R,4R,5R)-2-(5-Fluoro-2-oxo-4-((((pentyl-d11)oxy)carbonyl)amino)pyrimidin-1(2H)-yl)-5-methyltetrahydrofuran-3,4-diyl diacetate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : This is a deuterium labelled version an analog or impurity of Capecitabine. This can be used as an analytical labelled reference standard. Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. Capecitabine is a chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers.

References : PharmD C. M. et al.: Clinical Therapeutics, 27(1), 23-44, 2005; Guichard S. M. et al.: Eur J. Cancer, 44(2), 310-317, 2008.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.